They could have waited for the trial results... and then based off that knowledge patent VEPO. But they did so before even knowing the results. That shows you they had confidence in the drug and concerns about the trial. Then Culley goes to the R&R conference to plead with the investors about the drugs potential. Don't forget the previous multiple conferences where doctors spoke of the validity of the drug. Culley knew where the trial was headed...that's why they put a patent on it so early... that's why he attended the R&R conference. He was making his case towards the potential of the drug.
As statistical data was compiled it became clear that the grouping of data points was too close to the established threshold limits. That's why they filed for the extension because they saw it was going to be so close. Just needed a few more points to fall within threshold to carry the statistics back into the desired outcome.
But... the trial is over and that doesn't matter.
What does matter is that the drug itself... still offers hopeful potential. MAST knows they can't do it themselves.
Now we wait for validation of the drug..
We wait for a sale of VEPO, and we hope there us a bid war
The trial analysis will discover the validity of the potential of VEPO.
It's something to do with dosage. The trial didn't want to harm the many children involved.
They put a patent on VEPO. They rushed things at phase 2, without putting in more time they needed into affects of varying dosage strengths.
If your first trial failed, and you redesign the trial to involve a younger age group... you do so because of dosage. Adults blood is more complicated... plaques is a good example. They were concerned about the dosages and instead of upping the dosage, they thought a younger blood could make up the difference..
It's too early for the AIR001 to keep this floating.. it's still floating because it's obvious that post analysis may show that the drug itself.. is a step in the right direction.. and then the patent will enter auction.. in which a larger more experienced company can get involved.
MAST doesn't have the ability to take it any further.
But some company does.
Mast..most recently patented Vepo.
The trial tanked, and apparently Vepo too.
We know the trial failed, but we don't yet know why.
Often, there is a simple reason why.
For example... the dose of the medicine wasn't strong enough... the trial used a determined dosage.
Now take the fact that Culley just was at the R and R congerence. I bet he did hint that it was going to fail several weeks ago. I bet he found out a few days before he scheduled this conference attendance... casinos that something within the trial that made the trial fell he believes in VEPO.
He believes in it because he knows the drug works. This process has had to achieve benchmarks in order to get this far. Use your sense people.
So, in a few weeks... we'll find out that something happened with the trial but that doesn't mean the drug and science is a failure.
And then a real outfit will swoop down and buy the patent. That's the whole point of getting the patent you know the drug is good and it is your back up plan against the trial failing.
So in a few weeks that info will become available and we will see if I am on the right track.
Understanding that does make the shares very attractive investment right now..
In the comming weeks the company will review the data, and they will be able to pinpoint what exactly happened with the trial..
They could find out there is missing data.. the ultimate delay tactic... it's in the bag of tricks. There are bags of tricks
Or things like attrition bias.. find that.. and the game is still on.. going to be a delay that offers hope.
Or what about rater bias?
So we get efficacy failure for example.
Basically even though the trial is a failure... hope remains for VEPO... which explains Culley's recent invested conference he was just at. Setting up the groundwork to
SELL THE VEPO PATENT.
this is the gameplay..
They will now review it and see what went wrong and if they see something wrong they will perhas challenge it
Haha.. look at the spike up to $4 in the past... off what exactly? Nothing..lol
Something Shirley would bring more than nothing don't you think?
BLUE will also be interested... and I would guess maybe others.
Can you say "Bid war"?
Now about that patent..... we will piece that off as secondary sale. That would be on top of the 5.0 bid war sale.
EPIC fail.. the trial.. if the trial results are negative
Just like school you get a score.. not A thru F... but positive or negativel and then you pass or fail.
Did you believe this was only a positive or negative haha
Today at 11:40am time slot at the Rodman and Renshaw Conference..
He did not announce results.. that's what caused it to plunge.
He however did not announce a failure.. and that's why it has,is,will recover quickly.
And shares were exchanged..
Shorts covering and folks setting up stop loss orders. Manipulation told us a high possibility of an announcement.. inflated the price creating a orchestrated bubble knowing no announcement would be made. The perfect plan to cover the short positions... and make money off.. yes that's how it was. It took powerful conglomerates to do this.. which are known.
I bet today after the close..
The results are announced... positive
Just a complete hunch... lol
But... Nothing is what it ever is at the surface.. we need to ask questions, and we carry the burden of educating ourselves ..so that we ask all of the questions.
Questions for you to think about..
If he intends on presenting results in September... does that mean he knows the results now?
When results are ready.. doesn't he have to tell us.. not hold it for a later date if his choosing?
If results are not ready... he couldn't completely know anything... including the date they will know?